These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1500 related items for PubMed ID: 26133582

  • 1. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
    Williams JM, Rani SD, Li X, Arlinghaus LR, Lee TC, MacDonald LR, Partridge SC, Kang H, Whisenant JG, Abramson RG, Linden HM, Kinahan PE, Yankeelov TE.
    Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
    [Abstract] [Full Text] [Related]

  • 2. Prone Versus Supine Breast FDG-PET/CT for Assessing Locoregional Disease Distribution in Locally Advanced Breast Cancer.
    Abramson RG, Lambert KF, Jones-Jackson LB, Arlinghaus LR, Williams J, Abramson VG, Chakravarthy AB, Yankeelov TE.
    Acad Radiol; 2015 Jul; 22(7):853-9. PubMed ID: 25865435
    [Abstract] [Full Text] [Related]

  • 3. Variations in (18)F-FDG uptake in breast cancer depending on PET/CT acquisition position.
    Lee JH, Jeon TJ, Ahn SG, Jeong J, Seok JW, Ryu YH.
    Clin Radiol; 2016 Jan; 71(1):86-91. PubMed ID: 26646369
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Additional Prone 18F-FDG PET/CT Acquisition to Improve the Visualization of the Primary Tumor and Regional Lymph Node Metastases in Stage II/III Breast Cancer.
    Teixeira SC, Koolen BB, Vogel WV, Wesseling J, Stokkel MP, Vrancken Peeters MJ, van der Noort V, Rutgers EJ, Valdés Olmos RA.
    Clin Nucl Med; 2016 Apr; 41(4):e181-6. PubMed ID: 26704731
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Delineation of small mobile tumours with FDG-PET/CT in comparison to pathology in breast cancer patients.
    Hapdey S, Edet-Sanson A, Gouel P, Martin B, Modzelewski R, Baron M, Berghian A, Forestier-Lebreton F, Georgescu D, Picquenot JM, Gardin I, Dubray B, Vera P.
    Radiother Oncol; 2014 Sep; 112(3):407-12. PubMed ID: 25216573
    [Abstract] [Full Text] [Related]

  • 8. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L, Nicolai E, Luongo A, Aiello M, Catalano OA, Soricelli A, Salvatore M.
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [Abstract] [Full Text] [Related]

  • 9. Reliability of 18F-FDG PET Metabolic Parameters Derived Using Simultaneous PET/MRI and Correlation With Prognostic Factors of Invasive Ductal Carcinoma: A Feasibility Study.
    Jena A, Taneja S, Singh A, Negi P, Sarin R, Das PK, Singhal M.
    AJR Am J Roentgenol; 2017 Sep; 209(3):662-670. PubMed ID: 28678576
    [Abstract] [Full Text] [Related]

  • 10. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
    Schwenzer NF, Schmidt H, Gatidis S, Brendle C, Müller M, Königsrainer I, Claussen CD, Pfannenberg AC, Schraml C.
    J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Added value of prone position technique for PET-TAC in breast cancer patients].
    Vidal-Sicart S, Aukema TS, Vogel WV, Hoefnagel CA, Valdés-Olmos RA.
    Rev Esp Med Nucl; 2010 Nov; 29(5):230-5. PubMed ID: 20624663
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Test-Retest Variability in Lesion SUV and Lesion SUR in 18F-FDG PET: An Analysis of Data from Two Prospective Multicenter Trials.
    Hofheinz F, Apostolova I, Oehme L, Kotzerke J, van den Hoff J.
    J Nucl Med; 2017 Nov; 58(11):1770-1775. PubMed ID: 28473598
    [Abstract] [Full Text] [Related]

  • 18. 18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer.
    García Vicente AM, Soriano Castrejón A, Relea Calatayud F, Muñoz Madero V, Molina Garrido MJ, León Martín AA, Cordero García JM, Pilkington Woll JP, Chacón López-Muñiz I, Palomar Muñoz A.
    Rev Esp Med Nucl Imagen Mol; 2012 Nov; 31(6):308-14. PubMed ID: 23084013
    [Abstract] [Full Text] [Related]

  • 19. Preliminary analysis: Background parenchymal 18F-FDG uptake in breast cancer patients appears to correlate with background parenchymal enhancement and to vary by distance from the index cancer.
    Kim E, Mema E, Axelrod D, Sigmund E, Kim SG, Babb J, Melsaether AN.
    Eur J Radiol; 2019 Jan; 110():163-168. PubMed ID: 30599855
    [Abstract] [Full Text] [Related]

  • 20. Improved detection of breast cancer on FDG-PET cancer screening using breast positioning device.
    Kaida H, Ishibashi M, Fujii T, Kurata S, Ogo E, Tanaka M, Hayabuchi N.
    Ann Nucl Med; 2008 Feb; 22(2):95-101. PubMed ID: 18311533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 75.